Cernevit | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse Reactions from Clinical Trials: See Tables 3 and 4.

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

Post-marketing Adverse Reactions: The following adverse reactions have been reported in the post-marketing experience.
IMMUNE SYSTEM DISORDERS: Systemic hypersensitivity reactions with manifestations such as Respiratory distress, Chest discomfort, Throat tightness, Urticaria, Rash, Erythema, Epigastric discomfort, as well as Cardiac arrest with fatal outcome.
NERVOUS SYSTEM DISORDERS: Dysgeusia (metallic taste).
CARDIAC DISORDERS: Tachycardia.
RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS: Tachypnea.
GASTROINTESTINAL DISORDERS: Diarrhea.
SKIN AND SUBCUTANEOUS TISSUE DISORDERS: Pruritus.
HEPATOBILIARY DISORDERS: Gamma-glutamyltransferase increased.
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS: Pyrexia, Generalized aching, Infusion site reactions, i.e., Burning sensation, Rash.

View ADR Reporting Link

Cernevit Adverse Reactions

Manufacturer:

Baxter International

Distributor:

Zuellig Pharma